Verastem, Inc. (VSTM) stock
VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.87−0.54 (-7.29%)
Close on Nov 18, 2026Market cap $622.17MP/E –Yield –
Verastem revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Verastem's revenue for the twelve months ending Jun 30, 2026 was $87.53M. For fiscal 2025 it was $30.91M, up 209.1% from the year before. The highest annual figure on record is $88.52M in fiscal 2020.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.91M | +209.1% |
| FY2024 | Dec 31, 2024 | $10.00M | +285.2% |
| FY2022 | Dec 31, 2022 | $2.60M | +26.4% |
| FY2021 | Dec 31, 2021 | $2.05M | -97.7% |
| FY2020 | Dec 31, 2020 | $88.52M | +407.1% |
| FY2019 | Dec 31, 2019 | $17.46M | -34.7% |
| FY2018 | Dec 31, 2018 | $26.72M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $40.08M | +1775.4% |
| Q1 FY2026 | Mar 31, 2026 | $18.67M | – |
| Q4 FY2025 | Dec 31, 2025 | $17.54M | +75.4% |
| Q3 FY2025 | Sep 30, 2025 | $11.24M | – |
| Q2 FY2025 | Jun 30, 2025 | $2.14M | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
| Q1 FY2024 | Jun 30, 2024 | $10.00M | +285.2% |
| Q4 FY2022 | Dec 31, 2022 | $0 | -100.0% |
| Q3 FY2022 | Sep 30, 2022 | $0 | -100.0% |
| Q2 FY2022 | Jun 30, 2022 | $0 | -100.0% |
| Q1 FY2022 | Mar 31, 2022 | $2.60M | +158.1% |
| Q4 FY2021 | Dec 31, 2021 | $545.00K | +7.7% |
| Q3 FY2021 | Sep 30, 2021 | $2.00K | -100.0% |
| Q2 FY2021 | Jun 30, 2021 | $500.00K | -88.4% |
| Q1 FY2021 | Mar 31, 2021 | $1.01M | -80.1% |
| Q4 FY2020 | Dec 31, 2020 | $506.00K | -86.0% |
| Q3 FY2020 | Sep 30, 2020 | $78.65M | +770.8% |
| Q2 FY2020 | Jun 30, 2020 | $4.31M | +37.3% |
| Q1 FY2020 | Mar 31, 2020 | $5.06M | +202.6% |
| Q4 FY2019 | Dec 31, 2019 | $3.62M | +198.9% |
| Q3 FY2019 | Sep 30, 2019 | $9.03M | -41.8% |
| Q2 FY2019 | Jun 30, 2019 | $3.14M | -68.6% |
| Q1 FY2019 | Mar 31, 2019 | $1.67M | – |
| Q4 FY2018 | Dec 31, 2018 | $1.21M | – |
| Q3 FY2018 | Sep 30, 2018 | $15.51M | – |
| Q2 FY2018 | Jun 30, 2018 | $10.00M | – |
See a number that looks wrong?